King Wealth Biomarin Pharmaceutical Inc Transaction History

King Wealth

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $297,120 - $370,760	-4,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $71,720 - $91,470	-1,000 Reduced 20.0%	4,000 $353,000
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $373,650 - $453,450	5,000 New	5,000 $378,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.